Vanguard Group Inc. Has $1.79 Billion Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Vanguard Group Inc. lifted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 0.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,994,261 shares of the biopharmaceutical company’s stock after purchasing an additional 50,366 shares during the period. Vanguard […]
More Stories
DOJ Charges 28 Noncitizens in California With Election Crimes
By Tom Gantert The Justice Department announced on Oct. 19 that 28 noncitizens living in California face election-related criminal charges,...
Homebuilder Confidence Drops in October Amid Weak Demand, Rising Costs
By Bill Pan Confidence among U.S. homebuilders fell in October, as rising mortgage rates discouraged buyers while construction costs and...
Elon Musk Pledges to Give ‘Every Kid in America’ 1 SpaceX Share
By Andrew Moran Billionaire Elon Musk said he will give every child in the United States a stake in his...
Vance Says He’ll Wait Until After Midterms to Decide on Presidential Run
By Jack Phillips Vice President JD Vance said he will wait until after the upcoming November midterm elections before making...
Oil Retreats From 5-Month High as Markets Weigh Trump’s Russia Sanctions Waiver
By Tom Ozimek Oil prices fell on Oct. 19, with Brent retreating from a five-month high as investors weighed President...
The Babysitter 3: Renewal Status, Release Date, Cast Members & Plot
Nine years after Netflix’s debut, the horror-comedy film The Babysitter remains one of the biggest hits. What began as a...